ES8503953A1 - Un metodo de produccion de una preparacion de inmunoglobulina tumoral - Google Patents

Un metodo de produccion de una preparacion de inmunoglobulina tumoral

Info

Publication number
ES8503953A1
ES8503953A1 ES528118A ES528118A ES8503953A1 ES 8503953 A1 ES8503953 A1 ES 8503953A1 ES 528118 A ES528118 A ES 528118A ES 528118 A ES528118 A ES 528118A ES 8503953 A1 ES8503953 A1 ES 8503953A1
Authority
ES
Spain
Prior art keywords
plasma
tumor
prepared
compositions
normal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES528118A
Other languages
English (en)
Other versions
ES528118A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Publication of ES8503953A1 publication Critical patent/ES8503953A1/es
Publication of ES528118A0 publication Critical patent/ES528118A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6851—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

METODO DE PRODUCCION DE COMPOSICIONES DE INMUNOGLOBULINA TUMORAL DERIVADA DE UN HUESPED NORMAL DE UN HUESPED PORTADOR DE UN TUMOR, QUE TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DEL CANCER COMO LINFOMAS Y TUMORES SOLIDOS.CONSISTE EN ACIDULAR LA BAB-GLOBULINA DE UN SUERO NORMAL O DE UN SUERO DE PORTADORES DE TUMORES; NEUTRALIZAR EL PRODUCTO ACIDULADO Y SEPARAR EL PRECIPITADO DEB AB-GLOBULINA NEUTRALIZADA MEDIANTE FILTRACION.
ES528118A 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de inmunoglobulina tumoral Granted ES528118A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36643682A 1982-04-07 1982-04-07
US47236283A 1983-03-11 1983-03-11

Publications (2)

Publication Number Publication Date
ES8503953A1 true ES8503953A1 (es) 1985-04-16
ES528118A0 ES528118A0 (es) 1985-04-16

Family

ID=27003359

Family Applications (5)

Application Number Title Priority Date Filing Date
ES521279A Granted ES521279A0 (es) 1982-04-07 1983-04-06 Una inmunopreparacion tumoral.
ES528119A Expired ES8503954A1 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de proteina a-igg
ES528118A Granted ES528118A0 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de inmunoglobulina tumoral
ES528120A Expired ES8503950A1 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de plasma activada con zymosan
ES528121A Expired ES8601703A1 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de proteina a-igg

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES521279A Granted ES521279A0 (es) 1982-04-07 1983-04-06 Una inmunopreparacion tumoral.
ES528119A Expired ES8503954A1 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de proteina a-igg

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES528120A Expired ES8503950A1 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de plasma activada con zymosan
ES528121A Expired ES8601703A1 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de proteina a-igg

Country Status (13)

Country Link
EP (1) EP0091784B1 (es)
AU (2) AU569467B2 (es)
CA (1) CA1230555A (es)
DE (1) DE3374756D1 (es)
DK (1) DK154283A (es)
ES (5) ES521279A0 (es)
FI (1) FI831169L (es)
GB (2) GB2119803B (es)
GR (1) GR78514B (es)
NO (5) NO831223L (es)
PT (1) PT76505B (es)
RO (3) RO86661A (es)
ZW (1) ZW7583A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2161813B (en) * 1984-07-20 1988-07-13 Michiko Koga Anti-tumor agent
GB9013872D0 (en) * 1990-06-21 1990-08-15 Inst Tecnologico Y Cientifico Use of protein a and polypeptide components thereof in the treatment of tumours
EP0694066A4 (en) * 1993-04-08 1997-01-29 Univ Texas MODELS FOR GONOCOCCAL INFECTION
GB2422311A (en) * 2005-01-20 2006-07-26 Martin Lister Treatment of blood to cure disease
DE102005012594A1 (de) 2005-03-18 2006-09-21 Bayer Technology Services Gmbh Elektrofiltrationsverfahren
WO2010132847A1 (en) * 2009-05-14 2010-11-18 Oatmeal Biotechnologies Group, L.L.C. Platform technologies for spontaneously occurring diseases
EP3995141B1 (en) * 2016-04-28 2024-01-03 Alkahest, Inc. Plasma fractions as therapy for thymic cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
FI791551A (fi) * 1978-05-17 1979-11-18 Benzon As Alfred Renad cancer associerad protein

Also Published As

Publication number Publication date
GB2119803A (en) 1983-11-23
AU1286583A (en) 1983-10-13
ZW7583A1 (en) 1983-06-29
CA1230555A (en) 1987-12-22
PT76505A (en) 1983-05-01
NO841498L (no) 1983-10-10
AU569467B2 (en) 1988-02-04
AU1560088A (en) 1988-10-27
PT76505B (en) 1986-05-05
GB2163164B (en) 1986-09-03
DK154283D0 (da) 1983-04-07
ES528120A0 (es) 1985-04-16
NO841497L (no) 1983-10-10
DE3374756D1 (en) 1988-01-14
ES528121A0 (es) 1985-11-01
ES8601703A1 (es) 1985-11-01
GB2119803B (en) 1986-09-03
GB2163164A (en) 1986-02-19
ES528119A0 (es) 1985-04-16
EP0091784A3 (en) 1984-07-11
GR78514B (es) 1984-09-27
NO841495L (no) 1983-10-10
RO89498A (ro) 1986-06-30
GB8510892D0 (en) 1985-06-05
GB8309348D0 (en) 1983-05-11
EP0091784B1 (en) 1987-12-02
DK154283A (da) 1983-10-08
ES8503954A1 (es) 1985-04-16
RO89496A (ro) 1986-06-30
ES8405621A1 (es) 1984-06-16
NO841496L (no) 1983-10-10
FI831169A0 (fi) 1983-04-06
NO831223L (no) 1983-10-10
EP0091784A2 (en) 1983-10-19
ES8503950A1 (es) 1985-04-16
FI831169L (fi) 1983-10-08
ES521279A0 (es) 1984-06-16
RO86661A (ro) 1986-07-30
RO86661B (ro) 1985-03-01
ES528118A0 (es) 1985-04-16

Similar Documents

Publication Publication Date Title
PL254399A1 (en) Method of isolating a neoplasm necrosis effecting factor
GR3006492T3 (es)
IE830934L (en) 1,8-diaza-and 1,5,8-triazanaphthalene derivatives
DK545584D0 (da) Enzym-resistente immonumodulatoriske peptider
ATE88097T1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
ATE232394T1 (de) Verwendung von modifiziertem c-reaktiven protein zur herstellung eines medikaments zur behandlung von krebs
ES8405621A1 (es) Una inmunopreparacion tumoral.
DE3165965D1 (en) Blood-coagulation-promoting products and methods of preparing them
ES8502998A1 (es) Procedimiento para la preparacion de nuevas b-carbolinas substituidas.
DK292090D0 (da) Fremgangsmaade til fremstilling af et antithrombin iii-koncentrat
EP0325129A3 (en) Disubstituted pyridines
GR3005362T3 (es)
ES465180A1 (es) Procedimiento para la preparacion de preparados de inmuno- globulinas
KR950700684A (ko) 시클릭 항-종양 촉진제 화합물, 그의 조성물, 제조 방법 및 용도(Cyclic Anti-Tumor Promoter Compounds, Compositions and Methods for Production and Use)
JPS5756426A (en) Novel salt and manufacture
ES2012547A6 (es) Procedimiento para preparar una composicion farmaceutica que contiene metaloporfirinas.
IT1169788B (it) Procedimento per preparare composizioni contenenti gamma globulina
AU8083682A (en) Agent for treating allergic disease, immunuty complex diseaseand tumor
Lvovsky et al. Stimulation of hematopoietic stem cells by interferon inducer in nonhuman primates receiving fractionated total body irradiation
Nagel et al. Resistance of tumour cells to chemotherapy: importance of host defence factors
Thomas et al. Refractory and relapsing Hodgkin's disease: Role of high-dose chemotherapy with bone marrow transplantation
Okuhara Tumor Immunity Part 2. An Attempt at Immuno-Prophylaxis against Induction of DAB-Hepatoma
JPS5758630A (en) Interferon inducer
GB1254948A (en) Antivirial substance
Thar et al. Hodgkin's disease: Recurrence as related to size of disease, dose, and number of sites involved